Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• JustilienVAliSAJamiesonLEct2-dependent rRNA synthesis is required for KRAS-TRP53-driven lung adenocarcinomaCancer Cell201731225626928110998
   PubMed Web of Science ®Google Scholar
• TatsumotoTXieXBlumenthalROkamotoIMikiTHuman ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesisJ Cell Biol1999147592192810579713
   PubMed Web of Science ®Google Scholar
• WangHKLiangJFZhengHXXiaoHExpression and prognostic significance of ECT2 in invasive breast cancerJ Clin Pathol201871544244529051317
   PubMed Web of Science ®Google Scholar
• ChenZLiuJZhangYRole of epithelial cell transforming sequence 2 (ECT2) in predicting prognosis of osteosarcomaMed Sci Monit2017233861386828794404
   PubMed Web of Science ®Google Scholar
• JinYYuYShaoQUp-regulation of ECT2 is associated with poor prognosis in gastric cancer patientsInt J Clin Exp Pathol20147128724873125674238
   PubMed Web of Science ®Google Scholar
• SanoMGenkaiNYajimaNExpression level of ECT2 proto-oncogene correlates with prognosis in glioma patientsOncol Rep20061651093109817016598
   PubMed Web of Science ®Google Scholar
• JustilienVFieldsAPEct2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformationOncogene200928413597360719617897
   PubMed Web of Science ®Google Scholar
• XuHWuKTianYCD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancerInt J Oncol20164941343135027499099
   PubMed Web of Science ®Google Scholar
• ChuQHanNYuanXDACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cellsJ Hematol Oncol201477325322986
   PubMed Web of Science ®Google Scholar
• FromowitzFBViolaMVChaoSras p21 expression in the progression of breast cancerHum Pathol19871812126812753315956
   PubMed Web of Science ®Google Scholar
• WuKYuSLiuQBaiXZhengXWuKThe clinical significance of CXCL5 in non-small cell lung cancerOnco Targets Ther2017105561557329200871
   PubMed Web of Science ®Google Scholar
• XuHXWuKJTianYJHxXKjWExpression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: a systematic review and meta-analysisMedicine20169527e408527399099
   PubMed Web of Science ®Google Scholar
• LiuQLiATianYThe expression profile and clinic significance of the SIX family in non-small cell lung cancerJ Hematol Oncol20169111927821176
   PubMedGoogle Scholar
• ColdrenCDHelfrichBAWittaSEBaseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell linesMol Cancer Res20064852152816877703
   PubMed Web of Science ®Google Scholar
• PfisterTDReinholdWCAgamaKTopoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivityMol Cancer Ther2009871878188419584232
   PubMed Web of Science ®Google Scholar
• PolitiKHerbstRSLung cancer in the era of precision medicineClin Cancer Res201521102213222025979927
   PubMed Web of Science ®Google Scholar
• LiuQYuSZhaoWQinSChuQWuKEGFR-TKIs resistance via EGFR-independent signaling pathwaysMol Cancer20181715329455669
   PubMedGoogle Scholar
• GovindanRDingLGriffithMGenomic landscape of non-small cell lung cancer in smokers and never-smokersCell201215061121113422980976
   PubMed Web of Science ®Google Scholar
• LiuQLiAYuSTianYDACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosisJ Hematol Oncol20181115329636079
   PubMed Web of Science ®Google Scholar
• MimaeTOkadaMHagiyamaMUpregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stagesClin Cancer Res201218494595522190591
   PubMed Web of Science ®Google Scholar
• RomeroRSayinVIDavidsonSMKeap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysisNat Med201723111362136828967920
   PubMed Web of Science ®Google Scholar
• TianYLiuQHeXEmerging roles of Nrf2 signal in non-small cell lung cancerJ Hematol Oncol201691426922479
   PubMed Web of Science ®Google Scholar
• MikiTSmithCLLongJEEvaAFlemingTPOncogene ect2 is related to regulators of small GTP-binding proteinsNature199336264194624658464478
   PubMed Web of Science ®Google Scholar
• GuoJLGuSQLiYZhangXYEvaluation of clinical significance of endoglin expression during breast cancer and its correlation with ER and PCNAEur Rev Med Pharmacol Sci201721235402540729243782
   PubMed Web of Science ®Google Scholar
• MalkasLHHerbertBSAbdel-AzizWA cancer-associated PCNA expressed in breast cancer has implications as a potential biomarkerProc Natl Acad Sci U S A200610351194721947717159154
   PubMed Web of Science ®Google Scholar
• MansourMHauptSChanALThe E3-ligase E6AP represses breast cancer metastasis via regulation of ECT2-rho signalingCancer Res201676144236424827231202
   PubMed Web of Science ®Google Scholar
• LandiMTDrachevaTRotunnoMGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survivalPLoS One200832e165118297132
   PubMed Web of Science ®Google Scholar
• KunerRMuleyTMeisterMGlobal gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypesLung Cancer2009631323818486272
   PubMed Web of Science ®Google Scholar
• BatyFFacompréMKaiserSGene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancerAm J Respir Crit Care Med2010181218118819833826
   PubMed Web of Science ®Google Scholar
• TakeuchiTMinamiYIijimaTCharacteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomasPathol Int200656843443916872437
   PubMed Web of Science ®Google Scholar
• TomidaSTakeuchiTShimadaYRelapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosisJ Clin Oncol200927172793279919414676
   PubMed Web of Science ®Google Scholar
• ZhuCQDingKStrumpfDPrognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancerJ Clin Oncol201028294417442420823422
   PubMed Web of Science ®Google Scholar
• HouJAertsJden HamerBGene expression-based classification of non-small cell lung carcinomas and survival predictionPLoS One201054e1031220421987
   PubMed Web of Science ®Google Scholar
• LuTPTsaiMHLeeJMIdentification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking womenCancer Epidemiol Biomarkers Prev201019102590259720802022
   PubMed Web of Science ®Google Scholar
• XieYXiaoGCoombesKRRobust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patientsClin Cancer Res201117175705571421742808
   PubMed Web of Science ®Google Scholar
• RousseauxSDebernardiAJacquiauBEctopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancersSci Transl Med20135186186ra166
   Google Scholar
• OkayamaHKohnoTIshiiYIdentification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomasCancer Res201272110011122080568
   PubMed Web of Science ®Google Scholar
• BildAHYaoGChangJTOncogenic pathway signatures in human cancers as a guide to targeted therapiesNature2006439707435335716273092
   PubMed Web of Science ®Google Scholar
• SelamatSAChungBSGirardLGenome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expressionGenome Res20122271197121122613842
   PubMed Web of Science ®Google Scholar
• BotlingJEdlundKLohrMBiomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validationClin Cancer Res201319119420423032747
   PubMed Web of Science ®Google Scholar
• TangHXiaoGBehrensCA 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patientsClin Cancer Res20131961577158623357979
   PubMed Web of Science ®Google Scholar
• TarcaALLauriaMUngerMStrengths and limitations of micro-array-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature ChallengeBioinformatics201329222892289923966112
   PubMed Web of Science ®Google Scholar
• RaponiMZhangYYuJGene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lungCancer Res200666157466747216885343
   PubMed Web of Science ®Google Scholar
• DerSDSykesJPintilieMValidation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patientsJ Thorac Oncol201491596424305008
   PubMed Web of Science ®Google Scholar
• Director’s Challenge Consortium for the Molecular Classification of Lung AdenocarcinomaSheddenKTaylorJMGene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNat Med200814882282718641660
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkComprehensive genomic characterization of squamous cell lung cancersNature2012489741751952522960745
   PubMed Web of Science ®Google Scholar
• LeeESSonDSKimSHPrediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expressionClin Cancer Res200814227397740419010856
   PubMed Web of Science ®Google Scholar